Indigenous Peoples encounter numerous challenges in exercising their right to health. Lorna Rothery discussed the importance of collaborative and culturally sensitive approaches with Dr Sandra Del Pino, Advisor on Cultural Diversity at PAHO.
Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.
Researchers believe that they have found a PTSD marker in the brain region associated with emotional regulation - with the marker being strongest in people with "impaired executive dysfunction".
Astronauts need mental health strategies that work as they drift in space with isolation, confinement and strange light-dark cycles - so they go to the Antarctic.
Researchers at Harvard University found that Black women are four times more likely to die of COVID than white men - the data also revealed that Black women are three times more likely to die of the virus than Asian men.
In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.
Pfizer CEO Albert Bourla suggested that fully vaccinated people would need their third vaccine dose, maybe 12 months after they got their second - the EU is currently in talks to secure a further 1.8 billion doses.
According to HSJ, Health Secretary Matt Hancock's family-owned company were awarded an NHS contract for services - but the Secretary failed to declare any connection to Topwood Ltd.
An international study examined hospitalised COVID patients across 11 countries - finding that obese patients are 73% more likely to need invasive respiratory support.
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.
Here, we learn how world leading supplier Bioquell devised a PRP for a Biopharmaceutical Production Facility ensuring high-level bio-decontamination in the event of contamination.
